Evidence map›Paper›PMID 42835042›Full record

ArticleFrontiers in pharmacology2026

Evaluation of a multi-component AI-guided mechanistic reasoning practical in experimental pharmacology: a single-group pre-post study.

Maan H Harbi

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Maan H HarbiPharmacology and Toxicology Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExperimental pharmacology requires students to interpret laboratory findings, identify affected physiological pathways, and infer underlying drug mechanisms. While artificial intelligence (AI) is increasingly explored in health professions education, concerns remain regarding passive learning and overreliance on generated answers. This study evaluated the feasibility, acceptability, and short-term outcomes of a structured, multi-component practical designed to support active reasoning in antithrombotic pharmacology.

methodsA single-group pre-post educational intervention was conducted among 44 second-year PharmD students. The intervention included a baseline assessment, an experimental logic mini-brief, an AI-supported mechanistic reasoning practical using a standardized reasoning prompt, an independent post-test, and a perception survey. The primary outcome was total assessment score change. Secondary outcomes included domain-specific scores, performance during the AI-supported practical, confidence, perceived AI helpfulness, student perceptions, and associations between practical performance and learning outcomes.

resultsTotal assessment scores improved significantly from 76.82% ± 25.06% at baseline to 85.80% ± 21.27% after the intervention, with a mean gain of 8.98 ± 20.53 percentage points (Wilcoxon signed-rank test, Z = -2.597, p = 0.009, r = 0.39). Significant pre-post improvements were observed in coagulation pharmacology (p = 0.001, r = 0.49) and a smaller uncorrected improvement occurred in platelet pharmacology (p = 0.048, r = 0.30), while experimental reasoning scores increased numerically but did not reach statistical significance (p = 0.219, r = 0.19). Among AI-supported practical completers (n = 43), the mean Step 3 reasoning score was 17.88 ± 4.01 out of 21 (85.1% ± 19.1%). Accuracy was highest for experimental interpretation (87.0%), followed by mechanism or pathway identification (85.0%) and drug-class identification (83.4%). Step 3 performance was positively associated with post-test score (Spearman's rho = 0.606, p < 0.001). The core perception and acceptability items showed excellent internal consistency (Cronbach's alpha = 0.935), and student perceptions were generally favorable.

conclusionA multi-component pharmacology practical containing an AI-guided reasoning prompt was feasible, acceptable, and associated with improved short-term assessment scores. Given the single-group pre-post design, we cannot isolate the specific AI contribution from co-occurring instructional elements, such as the mini-brief, case-based practice, and retrieval-practice testing effects. Controlled studies are needed to assess causal efficacy and long-term retention.

Indexed as

antithrombotic pharmacologyartificial intelligenceexperimental pharmacologymechanistic reasoningpharmacology educationpharmacy education

Identifiers

PMID42835042
PMCPMC13634817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.